Clinicala evaluation of the effect Furovag in the treatment of Trichomonadosis of women
RU
Klinicheskaja ocenka lekarstvennojj cennosti preparata furovag, primenjaemogo pri trikhomonadoze u zhenshhin
Języki publikacji
PL
Abstrakty
EN
Furovag (furazolidone-N-5 Nitro-2-furfulidene 3-amino 2-oxazolide) was used to treat vaginal trichomonadosis in 50 women; the drug was administered for 6 days in the amount of 2 dragees and then for 8 days 1 dragée daily. A complete subsidence of the disease symptoms was found in 40% of cases. The follow- up examinination 4 weeks later showed the curative effect of the drug in 26%.